Polar Asset Management Partners Inc. Iovance Biotherapeutics, Inc. Transaction History

Polar Asset Management Partners Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $283,470 - $763,651	-85,900 Reduced 38.37%	138,000 $1.12 Million
Q3 2023 Nov 14, 2023	SELL	$4.44 - $8.79 $767,232 - $1.52 Million	-172,800 Reduced 43.56%	223,900 $1.02 Million
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $2.13 Million - $3.59 Million	396,700 New	396,700 $2.79 Million

340

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $912M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.